×
About 7,498 results

ALLMedicine™ Movement Disorders Center

Research & Reviews  2,511 results

What is the role of placebo in neurotherapeutics?
https://doi.org/10.1080/14737175.2022.2012156
Expert Review of Neurotherapeutics; Frisaldi E, Shaibani A et. al.

Dec 1st, 2021 - : The widespread use of the word "placebo" in the medical literature emphasizes the importance of this phenomenon in modern biomedical sciences. Neuroscientific research over the past thirty years shows that placebo effects are genuine psychobiolo...

Challenging Case: The Role of Genetic Testing in Complex Autism.
https://doi.org/10.1097/DBP.0000000000001045
Journal of Developmental and Behavioral Pediatrics : JDBP; Solgi M, Fernandez J et. al.

Nov 30th, 2021 - S is a 12-year-old boy with autism spectrum disorder (ASD), seizure disorder, cerebral palsy, and intellectual disability who presented to the primary care clinician for a preventative care visit.S was born at full term after an unremarkable pregn...

Machine learning in deep brain stimulation: A systematic review.
https://doi.org/10.1016/j.artmed.2021.102198
Artificial Intelligence in Medicine; Peralta M, Jannin P et. al.

Nov 27th, 2021 - Deep Brain Stimulation (DBS) is an increasingly common therapy for a large range of neurological disorders, such as abnormal movement disorders. The effectiveness of DBS in terms of controlling patient symptomatology has made this procedure increa...

Remission of functional motor symptoms following esketamine administration in a patient...
https://doi.org/10.1097/YIC.0000000000000378
International Clinical Psychopharmacology; Moccia L, Lanzotti P et. al.

Nov 27th, 2021 - Functional movement disorders (FMD) involve a broad range of abnormal involuntary movements not consistent with neurological diseases. These conditions often occur in combination with mood and anxiety disorders and are associated with poor clinica...

A Homozygous Missense Variant in PPP1R1B/DARPP-32 Is Associated With Generalized Comple...
https://doi.org/10.1002/mds.28861
Movement Disorders : Official Journal of the Movement Dis... Khan A, Molitor A et. al.

Nov 26th, 2021 - The dystonias are a heterogeneous group of hyperkinetic disorders characterized by sustained or intermittent muscle contractions that cause abnormal movements and/or postures. Although more than 200 causal genes are known, many cases of primary dy...

see more →

Guidelines  3 results

Guidelines for Speech Recording and Acoustic Analyses in Dysarthrias of Movement Disord...
https://doi.org/10.1002/mds.28465
Movement Disorders : Official Journal of the Movement Dis... Rusz J, Tykalova T et. al.

Dec 30th, 2020 - Most patients with movement disorders have speech impairments resulting from sensorimotor abnormalities that affect phonatory, articulatory, and prosodic speech subsystems. There is widespread cross-discipline use of speech recordings for diagnost...

ACR Appropriateness Criteria® Movement Disorders and Neurodegenerative Diseases.
https://doi.org/10.1016/j.jacr.2020.01.042
Journal of the American College of Radiology : JACR; , Harvey HB et. al.

May 7th, 2020 - Movement disorders and neurodegenerative diseases are a variety of conditions that involve progressive neuronal degeneration, injury, or death. Establishing the correct diagnosis of a movement disorder or neurodegenerative process can be difficult...

Dementia and movement disorders.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119123
AJNR. American Journal of Neuroradiology; Dormont D, Seidenwurm DJ et. al.

Jan 15th, 2008 - Dementia and movement disorders.|2008|Dormont D,Seidenwurm DJ, , ,|classification,complications,diagnosis,standards,classification,complications,diagnosis,

see more →

Drugs  7 results see all →

Clinicaltrials.gov  120 results

Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)
https://clinicaltrials.gov/ct2/show/NCT05126862

Nov 19th, 2021 - After being informed about the study and giving informed consent, participants will enroll in a pilot open trial of MindTrails, a web-based cognitive bias modification intervention. Participants will complete five, 20-minute MindTrails training se...

Botulinum Toxin for the Treatment of Involuntary Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT00001208

Nov 12th, 2021 - The efficacy of botulinum toxin (BTX) has now been demonstrated for a variety of diseases associated with involuntary muscles spasms or movement. The application of botulinum toxin therapy to movement disorders requires treatment tailored to the i...

The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome
https://clinicaltrials.gov/ct2/show/NCT05115318

Nov 10th, 2021 - Gilles de la Tourette syndrome (GTS) is a childhood onset neuropsychiatric disorder characterized by the presence of multiple motor and one or more phonic tics continuing for at least one year. In Israel, although consumption of cannabis is outlaw...

Modafinil for Freezing of Gait (FOG) in Parkinson's Disease (PD)
https://clinicaltrials.gov/ct2/show/NCT03083132

Oct 27th, 2021 - Freezing of gait is a late stage complication of Parkinson's disease in which patients note that their feet feel stuck or glued to the ground. This can lead to imbalance and falls and the secondary complications that can result from falls such as ...

Deep Brain Stimulation Surgery for Movement Disorders
https://clinicaltrials.gov/ct2/show/NCT01581580

Oct 26th, 2021 - Objective: The objective of this protocol is to provide DBS surgery and to collect physiology and efficacy data related to DBS therapy and motor and cognitive function in people with medically refractory Parkinson s disease (PD), dystonia, and ess...

see more →

News  347 results

Confirmed: No Slowing of Parkinson's Progression With Rasagiline
https://www.medscape.com/viewarticle/962868

Nov 12th, 2021 - A 1-mg daily dose of rasagiline has no disease-modifying effect for patients with Parkinson's disease (PD), new research confirms. Results from a randomized, double-blind, placebo-controlled trial support previous observations that free-water accu...

Type 2 Diabetes Worsens Parkinson's Disease
https://www.medscape.com/viewarticle/962501

Nov 8th, 2021 - Key Takeaways Among adults with recently diagnosed Parkinson's disease, those with concomitant type 2 diabetes had at study entry more severe motor symptoms and a greater overall burden of nonmotor symptoms compared with patients without type 2 di...

Influenza Tied to Long-Term Increased Risk for Parkinson's Disease
https://www.medscape.com/viewarticle/962028

Nov 1st, 2021 - Influenza infection is linked to a subsequent diagnosis of Parkinson's disease (PD) more than 10 years later, resurfacing a long-held debate about whether infection increases the risk for movement disorders over the long-term. In a large case-cont...

Avoidant attachment style may drive mood in movement disorders
https://www.mdedge.com/psychiatry/article/247468/movement-disorders/avoidant-attachment-style-may-drive-mood-movement
Heidi Splete

Oct 15th, 2021 - Patients with functional neurological disorders demonstrate higher levels of depression and alexithymia – in addition to signs of an avoidant attachment style – compared with those with other neurological disorders and healthy controls, investigat.

Safer Way to Use Botox to Treat Challenging Dystonia Type?
https://www.medscape.com/viewarticle/960304

Oct 5th, 2021 - When treating oromandibular dystonia (OMD) with botulinum toxin injection to the lateral pterygoid muscle (LPM), an intraoral approach is the safest way to avoid injury to the maxillary artery, new research suggests. OMD causes an involuntary open...

see more →

Patient Education  11 results see all →